The Constitutional Court’s decision dated 14 March 2024 and numbered 2023/160 E., 2023/160 E., 2024/77 K. annulled Article 18/A of the Law No. 6325 on Mediation in Civil Disputes (“Mediation Law”). The annulled provision imposed a sanction on parties causing the mediation to end due to their failure to attend the first mediation meeting without a valid excuse, holding them liable for all litigation costs and attorney fees, even if they were partially or fully justified in the…
»
The 12th Development Plan 2024–2028 (“Development Plan”) and the 2025 Presidential Annual Program (“Program”) set the development goals and strategic policies for various sectors in Türkiye.
In line with the Development Plan and Program, the pharmaceutical and medical device sectors are among those that emphasize key goals to increase Türkiye’s sustainability in the healthcare field, enhance domestic production capacity, and reduce dependency on imports. Overall, the aim is…
»
The principle of sustainability initially emerged as a corporate social responsibility notion under the management activities of companies and then, brought along the necessity for companies to act ethically and responsibly towards their stakeholders. The elements of environmental, social and economic sustainability are collectively at the core of corporate social responsibility and this concept is based on the responsibility of companies towards society.
It is observed that…
»
As of January 2024, there are 57.50 million social media users in Türkiye[1], and digital platforms hold the largest share of advertising investments at approximately 71.2% for the year 2024[2]. Within these digital investments, social media influencers account for 5%, underscoring their significant role in shaping consumer behaviour. Given the influence of social media influencers on consumption patterns, the importance of adhering to legal regulations concerning…
»
Evaluating Disparaging Practices against Competitors in the Pharmaceutical Sector: A Competition Law Perspective
The competition investigation initiated by the European Commission (the “Commission”) against Vifor Pharma on June 20, 2022, has attracted attention due to the fact that this is the first investigation in which the act of disparaging competitors will be considered as a violation of competition law alone. Competition investigations launched against pharmaceutical…
»
The World Health Organization (WHO) gives pharmaceutical substances international non-proprietary names (INNs) so that each substance can be identified by a distinct name. However, pharmaceutical trade marks cannot be composed entirely of INNs.
The rulings of the Court of Cassation (the CoC) indicate that while pharmaceutical trade marks can be derived from INNs, they cannot consist solely of these names.
For instance, an action was filed claiming that the defendant’s trade…
»
